DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Topotecan

Topotecan

  • SAAVTC Protocol

    SAAVTC Protocol

  • Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride

    Topotecan, Pegylated Liposomal Doxorubicin Hydrochloride

  • Tandem High-Dose Chemotherapy with Topotecan–Thiotepa–Carboplatin

    Tandem High-Dose Chemotherapy with Topotecan–Thiotepa–Carboplatin

  • Cyclophosphamide and Topotecan As First-Line Salvage Therapy in Patients with Relapsed Ewing Sarcoma at a Single Institution

    Cyclophosphamide and Topotecan As First-Line Salvage Therapy in Patients with Relapsed Ewing Sarcoma at a Single Institution

  • The Role of ABCG2 in Modulating Responses to Anti-Cancer Photodynamic Therapy

    The Role of ABCG2 in Modulating Responses to Anti-Cancer Photodynamic Therapy

  • BC Cancer Benefit Drug List September 2021

    BC Cancer Benefit Drug List September 2021

  • Arsenic Trioxide As a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study

    Arsenic Trioxide As a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study

  • Complications of Intrathecal Chemotherapy in Adults

    Complications of Intrathecal Chemotherapy in Adults

  • Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: a Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization

    Busulfan in Infant to Adult Hematopoietic Cell Transplant Recipients: a Population Pharmacokinetic Model for Initial and Bayesian Dose Personalization

  • Mobilization Topotecan–Filgrastim Combination Is an Effective Regimen

    Mobilization Topotecan–Filgrastim Combination Is an Effective Regimen

  • A Phase I Clinical Trial of the Poly(ADP-Ribose) Polymerase Inhibitor Veliparib And

    A Phase I Clinical Trial of the Poly(ADP-Ribose) Polymerase Inhibitor Veliparib And

  • Oral Topotecan Given Once Or Twice Daily for Ten Days: a Phase I Pharmacology Study in Adult Patients with Solid Tumors

    Oral Topotecan Given Once Or Twice Daily for Ten Days: a Phase I Pharmacology Study in Adult Patients with Solid Tumors

  • Chemotherapy and Polyneuropathies Grisold W, Oberndorfer S Windebank AJ European Association of Neurooncology Magazine 2012; 2 (1) 25-36

    Chemotherapy and Polyneuropathies Grisold W, Oberndorfer S Windebank AJ European Association of Neurooncology Magazine 2012; 2 (1) 25-36

  • Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors

    Based Photodynamic Diagnosis of Malignant Brain Tumor: Molecular Design of ABCG2 Inhibitors

  • CISPLATIN-TOPOTECAN (Intravenous)

    CISPLATIN-TOPOTECAN (Intravenous)

  • Photodiagnosis and Photodynamic Therapy 21 (2018) 121–127

    Photodiagnosis and Photodynamic Therapy 21 (2018) 121–127

  • Potential Role for Breast Cancer Resistance Protein in Clinical Drug-Drug Interactions

    Potential Role for Breast Cancer Resistance Protein in Clinical Drug-Drug Interactions

  • Topotecan: What Dose, What Schedule, What Route?1

    Topotecan: What Dose, What Schedule, What Route?1

Top View
  • The Microtubule-Stabilizing Agents Epothilones a and B and Their Desoxy-Derivatives Induce Mitotic Arrest and Apoptosis in Human Prostate Cancer Cells
  • Centre for Reviews and Dissemination Topotecan, Pegylated Liposomal
  • Pharmacokinetically Guided Phase I Trial of Topotecan and Etoposide Phosphate in Recurrent Ovarian Cancer
  • Phase II Study of Topotecan and Etoposide As Second-Line Treatment in Chemotherapy-Refractory Small-Cell Lung Cancer
  • Systemic MEK Inhibition Enhances the Efficacy of 5-Aminolevulinic Acid
  • Topotecan and Doxorubicin Combination to Treat Recurrent
  • 29, 37 Acantholytic Carcinoma, 141 Ac1arubicin, 214 Acquired
  • DRUG NAME: Topotecan
  • 2019 Table of Drugs
  • Topotecan and Doxorubicin Combination to Treat Recurrent
  • Feasibility and Correlates of Arsenic Trioxide Combined with Ascorbic
  • Identification of Cisplatin Sensitizers Through High-Throughput Combinatorial Screening
  • Hycamtin, INN-Topotecan
  • Full Prescribing Information for TOPOTECAN INJECTION
  • New Trends for Overcoming ABCG2/BCRP-Mediated Resistance
  • Emetogenic Potential of Antineoplastic Agents
  • HYCAMTIN 4 (Topotecan Hydrochloride) 5 for Injection 6 for INTRAVENOUS USE
  • A New Multidrug Reinduction Protocol with Topotecan, Vinorelbine


© 2024 Docslib.org    Feedback